Pancreatic Cancer Research

ResearcherEmory UniversityActive in the last 2 years

Tenzin Passang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3393-8161; OpenAlex author ID A5071196557. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-3628↗
  2. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41467-022-34242-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edmund K Waller · 2 shared papers, 2022–2024 · strength 0.32
  2. Sruthi Ravindranathan · 2 shared papers, 2022–2024 · strength 0.32
  3. Gregory B. Lesinski · 2 shared papers, 2022–2024 · strength 0.32
  4. Michael B. Ware · 1 shared paper, 2022 · strength 0.12
  5. Bassel F. El‐Rayes · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.